Interesting People mailing list archives

IP: Re: Canada Overrides Patent for Cipro to Treat Anthrax


From: David Farber <dave () farber net>
Date: Sun, 21 Oct 2001 15:02:30 -0400


Date:         Sun, 21 Oct 2001 13:05:31 EDT
From: Rich Wiggins <wiggins () msu edu>
Subject:      IP: Re: Canada Overrides Patent for Cipro to Treat Anthrax
To: David Farber <dave () farber net>

Dave,

Canada is not nationalizing the Bayer patent; it certainly isn't
nationalizing an industry.

The health minister, Allan Rock, placed an order for a generic
version of Cipro from a Canadian drug maker, Apotex.  Canada now
will enter negotiations with Bayer and may cancel the order.  Apotex
also asserts that it can make its generic Cipro without violating
Bayer's patents.  Apotex offered their generic for $1.50 CDN versus
Bayer's list price of $2.00 per pill.

NOTHING has been nationalized in this case. The prime minister was
out of the country; the parliament did not act on this; this was
a unilateral and probably reckless act by one minister.

See the attached article in the Toronto Globe and Mail
explaining the situation.  The assertion that the Canadian
action is akin to a socialist country nationalizing privately
owned industry is unsupportable.  Minister Rock is the subject
of considerable ridicule for placing the generic order in
the absence of a declared emergency and in the presence of
Bayer's statement that it can deliver what Canada requires.
It is likely that Bayer will be paid royalties or the
generic order will be canceled.

I think in these times, before people launch into long
philosophical treatises about the meaning of an international story,
they should acquaint themselves with the basic facts.  Think of
Allan Rock as Alexander ("I'm in charge") Haig or Earl Butz, not
Lenin or Castro.

(I just spent a week in the Canadian Rockies deprived of my New York Times,
so I happened to follow this story carefully.)

/rich

>From Saturday's Globe and Mail:

 http://www.globeandmail.com
 ---------------------------

globeandmail.com, Saturday, October 20, 2001
Ottawa weighs paying Bayer after ignoring Cipro patent

By SHAWN McCARTHY and LEONARD ZEHR
>From Saturday's Globe and Mail
BREAKING NEWS


Ottawa is considering compensating Bayer Canada after ignoring its own Patent
 Act in its rush to protect Canadians from anthrax  a scourge that has yet to
 emerge in this country.

 On Thursday, Health Canada ordered emergency supplies of the anti-anthrax
 medication ciprofloxacin from a generic manufacturer even though Bayer still
holds the patent. Bayer officials went on the offensive yesterday, saying the company has millions of tablets of its anti-anthrax medication, marketed under
 the name Cipro, in Toronto warehouses and has been willing and able to make
 those supplies available to Ottawa.


Bayer general manager Phil Blake said his company was prepared to deliver the
one million pills sought by Health Canada but was never asked. "At no stage did
 we tell Health Canada that we were unable to supply Cipro."

 Health Minister Allan Rock said his officials believed Bayer was unable to
deliver the amount of mediation required, and so turned to Toronto-based Apotex Inc., which produces a knock-off version of Cipro that it has not been able to
 market because Bayer holds the patent until 2004.

One senior Health official said that, while Bayer had the supplies, officials
 had questions about whether it was willing to supply them on the "terms and
 conditions" Ottawa was specifying.

 Mr. Rock would not say whether he will stick with the Apotex order now that
Bayer has said it has enough Cipro. The federal government could have sought an
 exemption to the patent legislation on the grounds that it was for a "public
 and non-commercial use," but officials did not make such a request when they
 placed the $1.3-million Apotex order.

Federal officials are to meet with Bayer next week, and likely will offer the
 German-based pharmaceutical giant compensation.

 Deputy Prime Minister Herb Gray ducked questions on whether Mr. Rock or
officials had broken the Patent Act. "I'm not going to give a legal opinion. As far as I'm aware, the department and its minister acted in good faith to take steps to protect the health of Canadians," he said. "I wouldn't be personally
 surprised if a settlement for Bayer was part of the discussion, but I'm not
 aware of all the topics" on the agenda of next week's meeting.

He played down concerns that his officials induced Apotex to break the Patent Act. "It is important that we respect the Patent Act and I think whatever we do
 has to be done lawfully, but that's not the real issue as far as I'm
 concerned," he said. "The real issue is whether we are in a position to meet
 our responsibility  my responsibility as Minister of Health  which is to get
the medications on hand that we may need in the unlikely event that something
 occurs."

Apotex president Jack Kay said, "For once, the government did the prudent thing
 and acted quickly."


For archives see:
http://www.interesting-people.org/archives/interesting-people/


Current thread: